Histopathology

Article	Citations
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction	943
The 2019 World Health Organization classification of tumours of the breast	394
Pulmonary and systemic involvement in COVID‐19 patients assessed with ultrasound‐guided minimally invasive autopsy	239
Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD	159
Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours	120
Third‐trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive women: histomorphology, including viral immunohistochemistry and in‐situ hybridization	110
Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies	87
Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion	79
Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China	77
Hunting coronavirus by transmission electron microscopy – a guide to SARS‐CoV‐2‐associated ultrastructural pathology in COVID‐19 tissues	75
Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series	58
When used together SS18–SSX fusion‐specific and SSX C‐terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in	56
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases	54
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)	54
Evolving classification of rhabdomyosarcoma	53
Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinoma	52
Primary high‐grade non‐anaplastic thyroid carcinoma: a retrospective study of 364 cases	49
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma	48
PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna	41
Updates on spread through air spaces (STAS) in lung cancer	41
Looking into digestive mixed neuroendocrine – nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors	41
Addition of the tumour–stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma	40
An introduction to the WHO 5th edition 2022 classification of testicular tumours	36
Gastric neuroendocrine tumours from long‐term proton pump inhibitor users are indolent tumours with good prognosis	34
Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33–RET fusions and BRAF V600E mutations	34

The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry	34
Poorly differentiated clusters in colorectal cancer: a current review and implications for future practice	33
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real‐time polymerase chain reaction	33
An update on the pathological classification of breast cancer	33
Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features	32
Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications	32
Non‐conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia	32
Pleomorphic adenoma: the great mimicker of malignancy	31
Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters	30
Artificial intelligence and algorithmic computational pathology: an introduction with renal allograft examples	29
The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression	29
Mesenchymal neoplasms with NTRK and other kinase gene alterations	29
Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes	29
Recent advances in the pathology of heritable gastric cancer syndromes	27
Head to head: should the intraductal component of invasive prostate cancer be graded?	27
Metastasis to the thyroid gland: a single‐institution 16‐year experience	27
Prognostic impact of combined progression index based on peritoneal grading regression score and peritoneal cytology in peritoneal metastasis	27
Development and validation of a supervised deep learning algorithm for automated whole‐slide programmed death‐ligand 1 tumour proportion score assessment in non‐small cell lung cancer	26
Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer	26
Adenomyoepithelioma of the breast: a proposal for classification	26
Superficial CD34‐positive fibroblastic tumor and PRDM10‐rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases	26
Identification of EWSR1–NFATC2 fusion in simple bone cysts	25
Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis	25
Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue	25
Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva	25
The prognostic significance of ALDH1A1 expression in early invasive breast cancer	25
Undifferentiated endometrial carcinoma arising in the background of high‐grade endometrial carcinoma – Expanding the definition of dedifferentiated endometrial carcinoma	25
Gastrointestinal tissue‐based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours	25
Medication‐specific variations in morphological patterns of injury in immune check‐point inhibitor‐associated colitis	25
Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence‐free survival in stages I–III colore	24
Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study	24
COVID‐19 related lung pathology: old patterns in new clothing?	24
Hepatocellular adenoma: what we know, what we do not know, and why it matters	24
Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading	23
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma	23
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus study	23
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification	23
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms	22
Social media in academics and research: 21st‐century tools to turbocharge education, collaboration, and dissemination of research findings	22
PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics	22
p53 immunohistochemical analysis of fusion‐positive uterine sarcomas	21
Feasibility and accuracy of pathological diagnosis in en‐bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging	21
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers	21
A multicentre analytical comparison study of inter‐reader and inter‐assay agreement of four programmed death‐ligand 1 immunohistochemistry assays for scoring in triple‐negative breast cancer	21
Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability	21
Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity	20
MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics	20
Diagnostic variability in the histopathological assessment of advanced colorectal adenomas and early colorectal cancer in a screening population	20
Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum	20
Mismatch repair deficiency is rare in bone and soft tissue tumors	19

Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies	19
Spitz melanocytic tumours – a review	19
Hereditary breast cancer: syndromes, tumour pathology and molecular testing	19
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status	19
Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy	18
Radiation‐associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation†	18
Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3‐MAML2 fusions, and clinicopathological features	18
Targeted therapy for upper gastrointestinal tract cancer: current and future prospects	18
The pathology of gastric and duodenal polyps: current concepts	17
Colitis‐associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy	17
Automated assessment of Ki‐67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging	17
Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases	17
PRAME expression in melanocytic lesions of the conjunctiva	17
Clinicopathological and molecular characterisation of USP6‐rearranged soft tissue neoplasms: the evidence of genetic relatedness indicates an expanding family with variable bone‐forming capacit	17
Clinicopathological findings in patients with COVID‐19‐associated ischaemic enterocolitis	17
Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study	17
The future of artificial intelligence in digital pathology – results of a survey across stakeholder groups	17
The histopathology of congenital haemangioma and its clinical correlations: a long‐term follow‐up study of 55 cases	17
Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint	17
Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2‐ rearranged salivary gland tumours	17
Gene fusion characterisation of rare aggressive prostate cancer variants—adenosquamous carcinoma, pleomorphic giant‐cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases	17
Taking tumour budding to the next frontier — a post International Tumour Budding Consensus Conference (ITBCC) 2016 review	17
p16 Immunoexpression in sinonasal and nasopharyngeal adenoid cystic carcinomas: a potential pitfall in ruling out HPV‐related multiphenotypic sinonasal carcinoma	16
Benign infiltrative myofibroblastic neoplasms of childhood with USP6 gene rearrangement	16
A case of pericytic neoplasm in the shoulder with a novel DERA–GLI1 gene fusion	16
Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer	16
Why is the histomorphological diagnosis of tumours of minor salivary glands much more difficult?	16
Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma	16
The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions	16
Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens	16
Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)	16
Cutaneous histiocytoses in children	16
DEVIL, VAAD and vLSC constitute a spectrum of HPV‐independent, p53‐independent intra‐epithelial neoplasia of the vulva	15
Update on triple‐negative breast cancers – highlighting subtyping update and treatment implication	15
‘I Can’t Keep Up!’: an update on advances in soft tissue pathology occurring after the publication of the 2020 World Health Organization classification of soft tissue and bone tumours	15
Advances in the classification of round cell sarcomas	15
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall	15
Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach	15
Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study	15
Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies	15
Novel APOD–GLI1 rearrangement in a sarcoma of unknown lineage	15
Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas	15
Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation	15
Comparison of different anti‐Ki67 antibody clones and hot‐spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis	15
Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6–NTRK3 fusion, and the rare KLHL7–BRAF fusi	15
Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital	15
DNA mismatch repair protein immunohistochemistry – an illustrated guide	14
PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis	14
Programmed cell death‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) expression in PD‐1 inhibitor‐associated colitis and its mimics	14
Improving Ki67 assessment concordance by the use of an artificial intelligence‐empowered microscope: a multi‐institutional ring study	14
Primary de‐differentiated, trans‐differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum	14
New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL‐cell tumours related to hypergastrinaemia	14
Pathology updates and diagnostic approaches to haemophagocytic lymphohistiocytosis	14
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management	14
Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant	14
Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision	14
Intratumoral CD103‐positive tumour‐infiltrating lymphocytes are associated with favourable prognosis in patients with triple‐negative breast cancer	14
NTRK‐rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class	14
Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences	14
A collaborative workflow between pathologists and deep learning for the evaluation of tumour cellularity in lung adenocarcinoma	13
Refining the definition of HER2‐low class in invasive breast cancer	13
ALK rearrangements in infantile fibrosarcoma‐like spindle cell tumours of soft tissue and kidney	13
Dataset for the reporting of carcinoma of the exocrine pancreas: recommendations from the International Collaboration on Cancer Reporting (ICCR)	13
NRAS Q61R immunohistochemical staining in thyroid pathology: sensitivity, specificity and utility	13
High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications	13
The spectrum of serrated colorectal lesions—new entities and unanswered questions	13
Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods	13
Histological features of BRAF V600E‐mutant anaplastic thyroid carcinoma	13
Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images	13
Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young	13
Molecular pathology of skin adnexal tumours	12
A rare but devastating cause of twin loss in a near‐term pregnancy highlighting the features of severe SARS‐CoV‐2 placentitis	12
Genomic profile of columnar cell variant of papillary thyroid carcinoma	12
What’s new in adipocytic neoplasia?	12
Cystic neutrophilic granulomatous mastitis – a review of 12 consecutive cases	12
Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics	12
YAP1–TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity	12
Programmed death‐ligand 1 expression in human papillomavirus‐independent cervical adenocarcinoma and its prognostic significance	12
Artificial intelligence in breast cancer histopathology	12
Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry	12

Novel EGFL7–FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease	12
Developing consensus in Histopathology: the role of the Delphi method	12
p16 overexpression and Rb loss correlate with high‐risk HPV infection in oropharyngeal squamous cell carcinoma	12
Challenges in Ki‐67 assessments in pulmonary large‐cell neuroendocrine carcinomas*	12
Post‐radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long‐term follow‐up and literature review	12
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer	12
Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements	12
Lynch syndrome screening in colorectal cancer: results of a prospective 2‐year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2‐million population	12
Increased histologic inflammation is an independent risk factor for nonconventional dysplasia in ulcerative colitis	12
Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach	12
NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25‐case cohort study	12
The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma	12
Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2	12
Recent advances in upper gastrointestinal lymphomas: molecular updates and diagnostic implications	11
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breast	11
Is nestin a diagnostic marker for combined hepatocellular–cholangiocarcinoma?	11
The genetics of vascular tumours: an update	11
Immunopathology of Kikuchi–Fujimoto disease: A reappraisal using novel immunohistochemistry markers	11
Why did they change that? Practical implications of the evolving classification of neuroendocrine tumours of the gastrointestinal tract	11
Distinct regulations driving YAP1 expression loss in poroma, porocarcinoma and RB1‐deficient skin carcinoma	11
Depth of invasion versus tumour thickness in early oral tongue squamous cell carcinoma: which measurement is the most practical and predictive of outcome?	11
MUC4 is expressed in alveolar rhabdomyosarcoma	11
Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas	11
Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours	11
A systematic comparison ofpan‐Trkimmunohistochemistry assays among multiple cancer types	11
Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study	11
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma	11
Epstein–Barr virus‐positive inflammatory follicular dendritic cell sarcoma presenting as a solitary colonic mass: two rare cases and a literature review	11
The solid variant of papillary thyroid carcinoma: a multi‐institutional retrospective study	11
Large cell calcifying Sertoli cell tumour: a contemporary multi‐institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry	11
PTEN expression and morphological patterns in prostatic adenocarcinoma	11
Clinicopathologic features of undetected dysplasia found in total colectomy or proctocolectomy specimens of patients with inflammatory bowel disease	11
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase‐targeted therapy	11
Diagnostic test accuracy meta‐analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions	11
Switch/sucrose‐non‐fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)‐deficient colorectal carcinomas are strongly associa	11
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis	11
Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma	11
Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis*	11
A comparative study of Kimura’s disease and IgG4‐related disease: similarities, differences and overlapping features	11
PRRX1–NCOA1‐rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under‐recognised, distinctive mesenchymal tumour	11
The human‐in‐the‐loop: an evaluation of pathologists’ interaction with artificial intelligence in clinical practice	11
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients	11
Development of a semi‐automated method for tumour budding assessment in colorectal cancer and comparison with manual methods	10
Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF‐1	10
Immunohistochemical detection of citrullinated histone H3‐positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody‐associated va	10
Concordance between core needle biopsy and surgical excision specimens for Ki‐67 in breast cancer – a systematic review of the literature	10
Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas	10
Comprehensive study of nine novel cases of TFEB‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression	10
Clinical and histopathological features of pulmonary sclerosing pneumocytoma with dense spindle stromal cells and lymph node metastasis	10
Clinicopathological analysis of low‐grade papillary Schneiderian carcinoma: report of five new cases and review of the literature	10
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix	10
Evaluation oncotype DX® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience	10
H3F3A‐mutated giant cell tumour of bone without giant cells—clinical presentation, radiology and histology of three cases	10
RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps	10
Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer	10
Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitonea	10
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)	10
Sporadic superficial angiomyxomas demonstrate loss of PRKAR1A expression	10
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma – a validation on an external data set	10
A simple digital image analysis system for automated Ki67 assessment in primary breast cancer	10
Ovarian microcystic stromal tumour: from morphological observations to syndromic associations	9
Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer	9
Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett’s oesophagus during routine clinical care	9
Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: a distinct entity among pancreatic tumors	9
Primary synovial sarcoma of bone: a retrospective analysis of 25 patients	9
Infectious diseases of the upper gastrointestinal tract	9
Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’	9
SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum	9
Survey of recurrent diagnostic challenges in breast phyllodes tumours	9
PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations	9
Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than in	9
Artificial intelligence for histological subtype classification of breast cancer: combining multi‐scale feature maps and the recurrent attention model	9
Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists	9
Perianal Paget’s disease as spread from non‐invasive colorectal adenomas	9
TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas	9
Histopathological and genetic features of mismatch repair‐deficient high‐grade prostate cancer	9
Clinicopathological, immunohistochemical and fluorescence in‐situ hybridisation features of early subungual melanoma: an analysis of 65 cases	9
Recent developments in gastroesophageal mesenchymal tumours	9
Inclusion of multiple high‐risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma	9
Establishing diagnostic criteria for mastocytosis in skin biopsies	9
Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies	9
Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence	9
Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series	9
Fibrin‐associated diffuse large B‐cell lymphoma misdiagnosed as breast implant‐associated anaplastic large‐cell lymphoma	9
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia	9
Risk factors for progression of appendiceal neuroendocrine tumours: low‐stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation	9
Non‐conventional dysplasia is frequently associated with low‐grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease	9
Cutaneous metastases of internal malignancies: a single‐institution experience	8
Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms	8
Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance	8
Whole‐exome analysis of metaplastic breast carcinomas with extensive osseous differentiation	8
Hypothesis: HEG1 and claudin‐4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non‐small‐cell lung carcinoma with only two stains in most cases	8
Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early‐stage luminal breast cancer	8
Evaluating the impact of lymph node resampling on colorectal cancer nodal stage	8
Stromal composition predicts recurrence of early rectal cancer after local excision	8